R&D Systems™ Recombinant Human TGF-beta 3 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 243B3002/CF

Catalog No. 243B3002CF

Description

Measured by its ability to inhibit the IL-4-dependent proliferation of HT-2 mouse T cells. Tsang, M. et al. (1995) Cytokine 7:389. The ED50 for this effect is 0.01-0.04 ng/mL.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.
• Molecular Weight (g/mol): 12.7 kDa (monomer)
• Quantity: 2μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: ARVD, ARVD1, FLJ16571, LDS5, RNHF, TGFB3, TGFbeta 3, TGF-beta3, TGF-beta-3, transforming growth factor beta-3, transforming growth factor, beta 3
• Recombinant: Recombinant

• Gene ID (Entrez): 7043
• Name: TGF-beta 3
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human TGF-beta 3 protein Ala301-Ser412 (Tyr340Phe)
• Structural Form: Disulfide-linked homodimer
• Conjugate: Unconjugated
• Purity or Quality Grade: 97%, by SDS-PAGE with silver staining.